Bullous disorders associated with PD-1 and PD-L1 inhibitors: Pharmacovigilance analysis of the United States Food and Drug Administration Adverse Event Reporting System from the Research on Adverse Drug Events And Reports Program

Javier Jimenez, Eran C. Gwillim, Cory Kosche, Anna Figueiredo, Corrine Rauck, Stephanie M. Rangel, Jennifer Choi, Dennis P. West, Beatrice Nardone*, Mario E. Lacouture

*Corresponding author for this work

Research output: Contribution to journalArticle

1 Scopus citations
Original languageEnglish (US)
JournalJournal of the American Academy of Dermatology
DOIs
StateAccepted/In press - Jan 1 2020

ASJC Scopus subject areas

  • Dermatology

Cite this